Sapient Capital LLC Milestone Pharmaceuticals Inc. Transaction History
Sapient Capital LLC
- $6.44 Billion
- Q3 2025
A detailed history of Sapient Capital LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Sapient Capital LLC holds 12,200 shares of MIST stock, worth $24,278. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,200Holding current value
$24,278% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIST
# of Institutions
54Shares Held
18.6MCall Options Held
160KPut Options Held
34.8K-
Black Rock Inc. New York, NY4.97MShares$9.89 Million0.0% of portfolio
-
Simplify Asset Management Inc. New York, NY2.83MShares$5.64 Million0.32% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.99 Million0.07% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.79MShares$3.57 Million4.22% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.4MShares$2.78 Million1.22% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $59.7M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...